Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy in uncomplicated Plasmodium falciparum malaria
ISRCTN08391109Phase 4Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Medicines for Malaria Venture. Primary endpoint: Parasite clearance time. Started Jul 2009; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN08391109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN08391109.